Changes in Breast Cancer Presentation during COVID-19: Experience in an Urban Academic Center
Open Access
- 9 June 2023
- journal article
- research article
- Published by Hindawi Limited in International Journal of Breast Cancer
- Vol. 2023, 1-4
Abstract
The COVID-19 pandemic strained healthcare systems worldwide, delaying breast cancer screening and surgery. In 2019, approximately 80 of breast cancers in the U.S. were diagnosed on screening examinations, with 76.4 of eligible Medicare patients undergoing screening at least every two years. Since the start of the pandemic, many women have been reluctant to seek elective screening mammography, even with the lifting of pandemic-related restrictions in access to routine healthcare. We describe the effect of the COVID-19 pandemic on breast cancer presentation at a tertiary academic medical center greatly impacted by the pandemic.Keywords
This publication has 18 references indexed in Scilit:
- Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling studyThe Lancet Oncology, 2020
- Risk Factors for Mortality in Patients with COVID-19 in New York CityJournal of General Internal Medicine, 2020
- COVID-19 and cancerScience, 2020
- COVID-19: Safe Guidelines for Breast Imaging During the PandemicCanadian Association of Radiologists Journal, 2020
- Cancer care in the time of COVID-19The Lancet Oncology, 2020
- Screening for Breast Cancer in Average-Risk Women: A Guidance Statement From the American College of PhysiciansAnnals of Internal Medicine, 2019
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methodsInternational Journal of Cancer, 2018
- Screening for Breast CancerRadiologic Clinics of North America, 2017
- Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from ItalyEuropean Journal of Cancer, 2017
- Effect of Screening and Adjuvant Therapy on Mortality from Breast CancerNew England Journal of Medicine, 2005